{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T07:22:11Z","timestamp":1781076131888,"version":"3.54.1"},"reference-count":39,"publisher":"Cambridge University Press (CUP)","issue":"13","license":[{"start":{"date-parts":[[2016,5,4]],"date-time":"2016-05-04T00:00:00Z","timestamp":1462320000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":["journals.cambridge.org"],"crossmark-restriction":true},"short-container-title":["Epidemiol. Infect."],"published-print":{"date-parts":[[2016,10]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>Skin and soft tissue infection (SSTIs) due to<jats:italic>Staphylococcus aureus<\/jats:italic>, particularly community-associated methicillin-resistant<jats:italic>Staphylococcus aureus<\/jats:italic>(CA-MRSA), are common in human immunodeficiency virus (HIV)-infected populations in the United States. Studies have differed as to the importance of epidemiological and immunological factors in this relationship, and have employed conflicting strategies for variable selection in multivariate analyses. Developments in causal inference methods in epidemiology have emerged in the last decade to clarify relationships between variables and identify appropriate variables to include in and exclude from multivariate analysis. In this paper, we develop a causal diagram to clarify the pathways linking CA-MRSA and HIV. We focus on the role played by trimethoprim-sulfamethoxazole (TMP-SMX) prophylaxis, prescribed to many severely immunocompromised HIV patients and potentially protective against SSTIs, which both mediates and moderates the relationship between immunological parameters and SSTI risk. We demonstrate, using simulated data, that statistical models may yield biased results if they do not account for how HIV viral load may also be a marker of adherence to TMP-SMX prophylaxis. We conclude with a proposed causal model that includes both the epidemiological as well as immunological factors that may explain the increased risk of initial and recurrent SSTI risk in HIV-infected populations.<\/jats:p>","DOI":"10.1017\/s0950268816000789","type":"journal-article","created":{"date-parts":[[2016,5,4]],"date-time":"2016-05-04T07:45:26Z","timestamp":1462347926000},"page":"2889-2898","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":2,"title":["The complex relationship between CD4 count, HIV viral load, trimethoprim-sulfamethoxazole prophylaxis, and skin-and-soft-tissue infection risk in patients with HIV: insights from a causal diagram and simulation study"],"prefix":"10.1017","volume":"144","author":[{"given":"V.","family":"HEMMIGE","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. S.","family":"LAUDERDALE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Z.","family":"DAVID","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2016,5,4]]},"reference":[{"key":"S0950268816000789_ref16","article-title":"Trends and factors associated with initial and recurrent methicillin-resistant Staphylococcus aureus (MRSA) skin and soft-tissue infections among HIV-infected persons: an 18-year study","author":"Vyas","year":"2013","journal-title":"Journal of the International Association of Providers of AIDS Care"},{"key":"S0950268816000789_ref37","doi-asserted-by":"publisher","DOI":"10.1097\/00001648-200009000-00011"},{"key":"S0950268816000789_ref31","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-1765(03)00032-6"},{"key":"S0950268816000789_ref1","volume-title":"Deadly Diseases and Epidemics: Staphyloccus aureus Infection","author":"Cook","year":"2006"},{"key":"S0950268816000789_ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-014-2237-1"},{"key":"S0950268816000789_ref9","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0560.2002.290307.x"},{"key":"S0950268816000789_ref8","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01423-08"},{"key":"S0950268816000789_ref21","unstructured":"Anon. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America."},{"key":"S0950268816000789_ref10","first-page":"153","article-title":"Community associated methicillin-resistant Staphylococcus aureus in HIV-infected patients","volume":"12","author":"Imaz","year":"2010","journal-title":"AIDS Reviews"},{"key":"S0950268816000789_ref34","article-title":"Estimating controlled direct effects in the presence of intermediate confounding of the mediator\u2013outcome relationship: comparison of five different methods","author":"Lepage","year":"2014","journal-title":"Statistical Methods in Medical Research"},{"key":"S0950268816000789_ref7","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.168.14.1585"},{"key":"S0950268816000789_ref5","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00081-09"},{"key":"S0950268816000789_ref2","first-page":"226","article-title":"On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenz\u00e6","volume":"10","author":"Fleming","year":"1929","journal-title":"British Journal of Experimental Pathology"},{"key":"S0950268816000789_ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2011.00978.x"},{"key":"S0950268816000789_ref11","doi-asserted-by":"publisher","DOI":"10.1086\/651076"},{"key":"S0950268816000789_ref4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.5219.124-a"},{"key":"S0950268816000789_ref26","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0b013e318225c2be"},{"key":"S0950268816000789_ref35","doi-asserted-by":"publisher","DOI":"10.1111\/resp.12238"},{"key":"S0950268816000789_ref29","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1086\/655761","article-title":"Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells\/\u03bcl?","volume":"51","author":"Mocroft","year":"2010","journal-title":"Clinical Infectious Diseases"},{"key":"S0950268816000789_ref27","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/15.3.413"},{"key":"S0950268816000789_ref24","doi-asserted-by":"publisher","DOI":"10.1097\/00001648-199901000-00008"},{"key":"S0950268816000789_ref22","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00315-11"},{"key":"S0950268816000789_ref12","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e318183a947"},{"key":"S0950268816000789_ref19","doi-asserted-by":"publisher","DOI":"10.1097\/01.qai.0000179464.40948.b9"},{"key":"S0950268816000789_ref13","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2008.0240"},{"key":"S0950268816000789_ref38","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0258(20000115)19:1<13::AID-SIM279>3.0.CO;2-5"},{"key":"S0950268816000789_ref3","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1963.03860010067005"},{"key":"S0950268816000789_ref6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.8.593"},{"key":"S0950268816000789_ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-013-0161-0"},{"key":"S0950268816000789_ref39","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit010"},{"key":"S0950268816000789_ref20","doi-asserted-by":"publisher","DOI":"10.1258\/095646207781439702"},{"key":"S0950268816000789_ref30","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables","volume":"34","author":"Cox","year":"1972","journal-title":"Journal of the Royal Statistical Society: Series B"},{"key":"S0950268816000789_ref17","doi-asserted-by":"publisher","DOI":"10.1086\/429827"},{"key":"S0950268816000789_ref28","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyt127"},{"key":"S0950268816000789_ref32","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1506816"},{"key":"S0950268816000789_ref33","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199806010-00003"},{"key":"S0950268816000789_ref23","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S7641"},{"key":"S0950268816000789_ref25","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfu325"},{"key":"S0950268816000789_ref36","doi-asserted-by":"publisher","DOI":"10.1097\/00001648-199207000-00007"}],"container-title":["Epidemiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0950268816000789","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T05:45:40Z","timestamp":1718516740000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0950268816000789\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,4]]},"references-count":39,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0950268816000789"],"URL":"https:\/\/doi.org\/10.1017\/s0950268816000789","relation":{},"ISSN":["0950-2688","1469-4409"],"issn-type":[{"value":"0950-2688","type":"print"},{"value":"1469-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,4]]},"assertion":[{"value":"Copyright \u00a9 Cambridge University Press 2016\u00a0","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}]}}